nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—TPO—Thyroxine (Thyroid Hormone) Production—SLC5A5—melanoma	0.0603	0.114	CbGpPWpGaD
Carbimazole—TPO—Thyroxine biosynthesis—SLC5A5—melanoma	0.0479	0.0906	CbGpPWpGaD
Carbimazole—TPO—Amine-derived hormones—SLC5A5—melanoma	0.0275	0.052	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—CSF3—melanoma	0.0226	0.0427	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—NODAL—melanoma	0.0201	0.0381	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—CXCR1—melanoma	0.0195	0.0369	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—WNT5A—melanoma	0.0148	0.0279	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—EPO—melanoma	0.0139	0.0262	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—CXCR4—melanoma	0.0129	0.0244	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—EPO—melanoma	0.012	0.0226	CbGpPWpGaD
Carbimazole—Myopathy—Temozolomide—melanoma	0.0102	0.0216	CcSEcCtD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—CSF2—melanoma	0.00968	0.0183	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—ITGB3—melanoma	0.00928	0.0175	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—RPP38—melanoma	0.00875	0.0165	CbGpPWpGaD
Carbimazole—Eosinophilia—Vemurafenib—melanoma	0.00869	0.0185	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of steroid hormones and vitamin D—CUBN—melanoma	0.00858	0.0162	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—HGF—melanoma	0.00846	0.016	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—SLC6A11—melanoma	0.00838	0.0158	CbGpPWpGaD
Carbimazole—Foetor hepaticus—Docetaxel—melanoma	0.00838	0.0178	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—FGF1—melanoma	0.00836	0.0158	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—MTAP—melanoma	0.00815	0.0154	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—NOTCH1—melanoma	0.00743	0.014	CbGpPWpGaD
Carbimazole—Aplastic anaemia—Dactinomycin—melanoma	0.00742	0.0158	CcSEcCtD
Carbimazole—TPO—Amino acid and derivative metabolism—PHGDH—melanoma	0.00727	0.0137	CbGpPWpGaD
Carbimazole—Mouth ulceration—Dactinomycin—melanoma	0.00715	0.0152	CcSEcCtD
Carbimazole—Liver disorder—Docetaxel—melanoma	0.00697	0.0148	CcSEcCtD
Carbimazole—CYP19A1—Endogenous sterols—CYP17A1—melanoma	0.0069	0.013	CbGpPWpGaD
Carbimazole—Aplastic anaemia—Temozolomide—melanoma	0.00671	0.0143	CcSEcCtD
Carbimazole—Throat sore—Docetaxel—melanoma	0.0066	0.014	CcSEcCtD
Carbimazole—Oropharyngeal discomfort—Docetaxel—melanoma	0.00654	0.0139	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—NOTCH1—melanoma	0.00642	0.0121	CbGpPWpGaD
Carbimazole—Angiopathy—Vemurafenib—melanoma	0.00637	0.0135	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—KIT—melanoma	0.00628	0.0119	CbGpPWpGaD
Carbimazole—Alopecia—Vemurafenib—melanoma	0.00621	0.0132	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—EGF—melanoma	0.00621	0.0117	CbGpPWpGaD
Carbimazole—Ageusia—Docetaxel—melanoma	0.00587	0.0125	CcSEcCtD
Carbimazole—CYP19A1—Endogenous sterols—CYP1B1—melanoma	0.00581	0.011	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—IGF1—melanoma	0.00575	0.0109	CbGpPWpGaD
Carbimazole—CYP19A1—Ovarian Infertility Genes—MLH1—melanoma	0.00553	0.0105	CbGpPWpGaD
Carbimazole—Liver function test abnormal—Dactinomycin—melanoma	0.0053	0.0112	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—FGF2—melanoma	0.00529	0.00999	CbGpPWpGaD
Carbimazole—Oropharyngeal pain—Docetaxel—melanoma	0.00523	0.0111	CcSEcCtD
Carbimazole—Myalgia—Vemurafenib—melanoma	0.00521	0.0111	CcSEcCtD
Carbimazole—Arthralgia—Vemurafenib—melanoma	0.00521	0.0111	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00517	0.011	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP17A1—melanoma	0.00517	0.00977	CbGpPWpGaD
Carbimazole—Pancytopenia—Bleomycin—melanoma	0.00505	0.0107	CcSEcCtD
Carbimazole—Infection—Vemurafenib—melanoma	0.00496	0.0105	CcSEcCtD
Carbimazole—Liver function test abnormal—Carmustine—melanoma	0.00496	0.0105	CcSEcCtD
Carbimazole—Nervous system disorder—Vemurafenib—melanoma	0.00489	0.0104	CcSEcCtD
Carbimazole—Skin disorder—Vemurafenib—melanoma	0.00485	0.0103	CcSEcCtD
Carbimazole—Hepatocellular injury—Docetaxel—melanoma	0.00475	0.0101	CcSEcCtD
Carbimazole—Pancytopenia—Dactinomycin—melanoma	0.00471	0.01	CcSEcCtD
Carbimazole—Neutropenia—Dactinomycin—melanoma	0.00464	0.00985	CcSEcCtD
Carbimazole—Stomatitis—Bleomycin—melanoma	0.00462	0.00981	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00455	0.00965	CcSEcCtD
Carbimazole—Pancytopenia—Carmustine—melanoma	0.00441	0.00936	CcSEcCtD
Carbimazole—Neutropenia—Carmustine—melanoma	0.00434	0.00922	CcSEcCtD
Carbimazole—Stomatitis—Dactinomycin—melanoma	0.00431	0.00915	CcSEcCtD
Carbimazole—Haemoglobin—Bleomycin—melanoma	0.00428	0.00908	CcSEcCtD
Carbimazole—Pancytopenia—Temozolomide—melanoma	0.00426	0.00904	CcSEcCtD
Carbimazole—Haemorrhage—Bleomycin—melanoma	0.00426	0.00904	CcSEcCtD
Carbimazole—Neutropenia—Temozolomide—melanoma	0.00419	0.00891	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—UGT2B10—melanoma	0.00414	0.00783	CbGpPWpGaD
Carbimazole—Agranulocytosis—Dactinomycin—melanoma	0.00413	0.00876	CcSEcCtD
Carbimazole—Stomatitis—Carmustine—melanoma	0.00403	0.00857	CcSEcCtD
Carbimazole—Hepatitis—Dactinomycin—melanoma	0.00397	0.00843	CcSEcCtD
Carbimazole—Body temperature increased—Vemurafenib—melanoma	0.00395	0.00838	CcSEcCtD
Carbimazole—Stomatitis—Temozolomide—melanoma	0.0039	0.00828	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—PRKCA—melanoma	0.00387	0.00732	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—SLC5A5—melanoma	0.00383	0.00725	CbGpPWpGaD
Carbimazole—Alopecia—Bleomycin—melanoma	0.00376	0.00799	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—VEGFA—melanoma	0.00376	0.0071	CbGpPWpGaD
Carbimazole—Haemoglobin—Carmustine—melanoma	0.00373	0.00793	CcSEcCtD
Carbimazole—Haemorrhage—Carmustine—melanoma	0.00372	0.00789	CcSEcCtD
Carbimazole—Hypersensitivity—Vemurafenib—melanoma	0.00368	0.00781	CcSEcCtD
Carbimazole—CYP19A1—Ovarian Infertility Genes—VDR—melanoma	0.00366	0.00693	CbGpPWpGaD
Carbimazole—Haemoglobin—Temozolomide—melanoma	0.00361	0.00766	CcSEcCtD
Carbimazole—Hepatitis—Temozolomide—melanoma	0.00359	0.00762	CcSEcCtD
Carbimazole—Haemorrhage—Temozolomide—melanoma	0.00359	0.00762	CcSEcCtD
Carbimazole—Pruritus—Vemurafenib—melanoma	0.00353	0.0075	CcSEcCtD
Carbimazole—Alopecia—Dactinomycin—melanoma	0.00351	0.00745	CcSEcCtD
Carbimazole—Ill-defined disorder—Bleomycin—melanoma	0.00344	0.0073	CcSEcCtD
Carbimazole—Malaise—Bleomycin—melanoma	0.00334	0.00709	CcSEcCtD
Carbimazole—CYP19A1—Tryptophan metabolism—CYP1B1—melanoma	0.00334	0.00631	CbGpPWpGaD
Carbimazole—Leukopenia—Bleomycin—melanoma	0.00332	0.00704	CcSEcCtD
Carbimazole—Alopecia—Carmustine—melanoma	0.00328	0.00697	CcSEcCtD
Carbimazole—Angiopathy—Temozolomide—melanoma	0.00326	0.00692	CcSEcCtD
Carbimazole—Ill-defined disorder—Dactinomycin—melanoma	0.00321	0.00681	CcSEcCtD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	0.0032	0.00606	CbGpPWpGaD
Carbimazole—Liver function test abnormal—Docetaxel—melanoma	0.00319	0.00677	CcSEcCtD
Carbimazole—Alopecia—Temozolomide—melanoma	0.00317	0.00674	CcSEcCtD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP17A1—melanoma	0.00316	0.00598	CbGpPWpGaD
Carbimazole—Myalgia—Bleomycin—melanoma	0.00315	0.0067	CcSEcCtD
Carbimazole—Rash—Vemurafenib—melanoma	0.00315	0.00668	CcSEcCtD
Carbimazole—Dermatitis—Vemurafenib—melanoma	0.00314	0.00668	CcSEcCtD
Carbimazole—Headache—Vemurafenib—melanoma	0.00313	0.00664	CcSEcCtD
Carbimazole—Discomfort—Bleomycin—melanoma	0.00312	0.00662	CcSEcCtD
Carbimazole—Malaise—Dactinomycin—melanoma	0.00312	0.00662	CcSEcCtD
Carbimazole—Leukopenia—Dactinomycin—melanoma	0.00309	0.00657	CcSEcCtD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—IL6—melanoma	0.00301	0.00568	CbGpPWpGaD
Carbimazole—Infection—Bleomycin—melanoma	0.003	0.00638	CcSEcCtD
Carbimazole—Nausea—Vemurafenib—melanoma	0.00296	0.00629	CcSEcCtD
Carbimazole—Thrombocytopenia—Bleomycin—melanoma	0.00296	0.00629	CcSEcCtD
Carbimazole—Myalgia—Dactinomycin—melanoma	0.00294	0.00625	CcSEcCtD
Carbimazole—Discomfort—Dactinomycin—melanoma	0.00291	0.00617	CcSEcCtD
Carbimazole—Ill-defined disorder—Temozolomide—melanoma	0.0029	0.00616	CcSEcCtD
Carbimazole—Leukopenia—Carmustine—melanoma	0.00289	0.00615	CcSEcCtD
Carbimazole—Angioedema—Temozolomide—melanoma	0.00286	0.00606	CcSEcCtD
Carbimazole—Pancytopenia—Docetaxel—melanoma	0.00283	0.00601	CcSEcCtD
Carbimazole—CYP19A1—Ovarian Infertility Genes—ATM—melanoma	0.00282	0.00534	CbGpPWpGaD
Carbimazole—Malaise—Temozolomide—melanoma	0.00282	0.00598	CcSEcCtD
Carbimazole—CYP19A1—Ovarian Infertility Genes—CDK4—melanoma	0.00281	0.00532	CbGpPWpGaD
Carbimazole—Infection—Dactinomycin—melanoma	0.0028	0.00595	CcSEcCtD
Carbimazole—Leukopenia—Temozolomide—melanoma	0.0028	0.00594	CcSEcCtD
Carbimazole—Neutropenia—Docetaxel—melanoma	0.00279	0.00592	CcSEcCtD
Carbimazole—Thrombocytopenia—Dactinomycin—melanoma	0.00276	0.00586	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Bleomycin—melanoma	0.00275	0.00585	CcSEcCtD
Carbimazole—Myalgia—Carmustine—melanoma	0.00275	0.00585	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—XRCC3—melanoma	0.00275	0.0052	CbGpPWpGaD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.0027	0.0051	CbGpPWpGaD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.00266	0.00503	CbGpPWpGaD
Carbimazole—Myalgia—Temozolomide—melanoma	0.00266	0.00565	CcSEcCtD
Carbimazole—Arthralgia—Temozolomide—melanoma	0.00266	0.00565	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00264	0.00561	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—AKR1B10—melanoma	0.00263	0.00497	CbGpPWpGaD
Carbimazole—Discomfort—Temozolomide—melanoma	0.00263	0.00558	CcSEcCtD
Carbimazole—Infection—Carmustine—melanoma	0.00262	0.00557	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.0026	0.00491	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—IL6—melanoma	0.0026	0.00491	CbGpPWpGaD
Carbimazole—Jaundice—Docetaxel—melanoma	0.00259	0.0055	CcSEcCtD
Carbimazole—Stomatitis—Docetaxel—melanoma	0.00259	0.0055	CcSEcCtD
Carbimazole—Thrombocytopenia—Carmustine—melanoma	0.00258	0.00549	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00257	0.00546	CcSEcCtD
Carbimazole—TPO—Metabolism—ACER3—melanoma	0.00254	0.0048	CbGpPWpGaD
Carbimazole—Infection—Temozolomide—melanoma	0.00253	0.00538	CcSEcCtD
Carbimazole—Nervous system disorder—Temozolomide—melanoma	0.0025	0.00531	CcSEcCtD
Carbimazole—Thrombocytopenia—Temozolomide—melanoma	0.0025	0.0053	CcSEcCtD
Carbimazole—Feeling abnormal—Bleomycin—melanoma	0.00249	0.00529	CcSEcCtD
Carbimazole—Agranulocytosis—Docetaxel—melanoma	0.00248	0.00527	CcSEcCtD
Carbimazole—Skin disorder—Temozolomide—melanoma	0.00248	0.00526	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Carmustine—melanoma	0.0024	0.00511	CcSEcCtD
Carbimazole—Urticaria—Bleomycin—melanoma	0.0024	0.0051	CcSEcCtD
Carbimazole—Haemoglobin—Docetaxel—melanoma	0.0024	0.0051	CcSEcCtD
Carbimazole—Body temperature increased—Bleomycin—melanoma	0.00239	0.00508	CcSEcCtD
Carbimazole—Hepatitis—Docetaxel—melanoma	0.00239	0.00507	CcSEcCtD
Carbimazole—Haemorrhage—Docetaxel—melanoma	0.00239	0.00507	CcSEcCtD
Carbimazole—Feeling abnormal—Dactinomycin—melanoma	0.00232	0.00493	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Temozolomide—melanoma	0.00232	0.00493	CcSEcCtD
Carbimazole—TPO—Metabolism—UGT2B10—melanoma	0.00232	0.00439	CbGpPWpGaD
Carbimazole—Body temperature increased—Dactinomycin—melanoma	0.00223	0.00473	CcSEcCtD
Carbimazole—Hypersensitivity—Bleomycin—melanoma	0.00223	0.00473	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.00219	0.00413	CbGpPWpGaD
Carbimazole—Feeling abnormal—Carmustine—melanoma	0.00218	0.00462	CcSEcCtD
Carbimazole—Angiopathy—Docetaxel—melanoma	0.00217	0.0046	CcSEcCtD
Carbimazole—TPO—Metabolism—HS3ST5—melanoma	0.00216	0.00408	CbGpPWpGaD
Carbimazole—Pruritus—Bleomycin—melanoma	0.00214	0.00454	CcSEcCtD
Carbimazole—Alopecia—Docetaxel—melanoma	0.00211	0.00448	CcSEcCtD
Carbimazole—Feeling abnormal—Temozolomide—melanoma	0.0021	0.00446	CcSEcCtD
Carbimazole—Body temperature increased—Carmustine—melanoma	0.00209	0.00443	CcSEcCtD
Carbimazole—Hypersensitivity—Dactinomycin—melanoma	0.00208	0.00441	CcSEcCtD
Carbimazole—Urticaria—Temozolomide—melanoma	0.00203	0.0043	CcSEcCtD
Carbimazole—Body temperature increased—Temozolomide—melanoma	0.00202	0.00428	CcSEcCtD
Carbimazole—Hypersensitivity—Carmustine—melanoma	0.00194	0.00413	CcSEcCtD
Carbimazole—Rash—Bleomycin—melanoma	0.00191	0.00405	CcSEcCtD
Carbimazole—Dermatitis—Bleomycin—melanoma	0.0019	0.00404	CcSEcCtD
Carbimazole—CYP19A1—Ovarian Infertility Genes—CDKN1B—melanoma	0.0019	0.0036	CbGpPWpGaD
Carbimazole—Hypersensitivity—Temozolomide—melanoma	0.00188	0.00399	CcSEcCtD
Carbimazole—Leukopenia—Docetaxel—melanoma	0.00186	0.00395	CcSEcCtD
Carbimazole—Pruritus—Temozolomide—melanoma	0.0018	0.00383	CcSEcCtD
Carbimazole—Nausea—Bleomycin—melanoma	0.0018	0.00381	CcSEcCtD
Carbimazole—Rash—Dactinomycin—melanoma	0.00178	0.00378	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MSH2—melanoma	0.00177	0.00335	CbGpPWpGaD
Carbimazole—Myalgia—Docetaxel—melanoma	0.00177	0.00376	CcSEcCtD
Carbimazole—Arthralgia—Docetaxel—melanoma	0.00177	0.00376	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00176	0.00373	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.00174	0.00329	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—MAPK3—melanoma	0.00172	0.00324	CbGpPWpGaD
Carbimazole—Infection—Docetaxel—melanoma	0.00169	0.00358	CcSEcCtD
Carbimazole—Nausea—Dactinomycin—melanoma	0.00168	0.00356	CcSEcCtD
Carbimazole—Rash—Carmustine—melanoma	0.00166	0.00353	CcSEcCtD
Carbimazole—Nervous system disorder—Docetaxel—melanoma	0.00166	0.00353	CcSEcCtD
Carbimazole—Dermatitis—Carmustine—melanoma	0.00166	0.00353	CcSEcCtD
Carbimazole—Thrombocytopenia—Docetaxel—melanoma	0.00166	0.00353	CcSEcCtD
Carbimazole—Headache—Carmustine—melanoma	0.00165	0.00351	CcSEcCtD
Carbimazole—Skin disorder—Docetaxel—melanoma	0.00165	0.0035	CcSEcCtD
Carbimazole—TPO—Metabolism—PLCB4—melanoma	0.00164	0.00309	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—MAPK1—melanoma	0.00163	0.00309	CbGpPWpGaD
Carbimazole—Rash—Temozolomide—melanoma	0.00161	0.00341	CcSEcCtD
Carbimazole—Dermatitis—Temozolomide—melanoma	0.00161	0.00341	CcSEcCtD
Carbimazole—Headache—Temozolomide—melanoma	0.0016	0.00339	CcSEcCtD
Carbimazole—Nausea—Carmustine—melanoma	0.00157	0.00333	CcSEcCtD
Carbimazole—CYP19A1—Tryptophan metabolism—MDM2—melanoma	0.00156	0.00295	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Docetaxel—melanoma	0.00155	0.00328	CcSEcCtD
Carbimazole—TPO—Metabolism—SLC6A11—melanoma	0.00154	0.00291	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIP4K2A—melanoma	0.00154	0.00291	CbGpPWpGaD
Carbimazole—Nausea—Temozolomide—melanoma	0.00152	0.00322	CcSEcCtD
Carbimazole—TPO—Metabolism—MTAP—melanoma	0.0015	0.00283	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AURKA—melanoma	0.00145	0.00273	CbGpPWpGaD
Carbimazole—Feeling abnormal—Docetaxel—melanoma	0.0014	0.00297	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—CYP17A1—melanoma	0.00138	0.00261	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP17A1—melanoma	0.00136	0.00257	CbGpPWpGaD
Carbimazole—Body temperature increased—Docetaxel—melanoma	0.00134	0.00285	CcSEcCtD
Carbimazole—TPO—Metabolism—PHGDH—melanoma	0.00133	0.00252	CbGpPWpGaD
Carbimazole—TPO—Metabolism—LUM—melanoma	0.00133	0.00252	CbGpPWpGaD
Carbimazole—TPO—Metabolism—HPSE—melanoma	0.00131	0.00247	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CUBN—melanoma	0.00128	0.00243	CbGpPWpGaD
Carbimazole—Hypersensitivity—Docetaxel—melanoma	0.00125	0.00265	CcSEcCtD
Carbimazole—TPO—Metabolism—SDHD—melanoma	0.00124	0.00235	CbGpPWpGaD
Carbimazole—TPO—Metabolism—BSG—melanoma	0.00124	0.00235	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CSPG4—melanoma	0.00124	0.00235	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GPAM—melanoma	0.0012	0.00227	CbGpPWpGaD
Carbimazole—Pruritus—Docetaxel—melanoma	0.0012	0.00255	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—CYP1B1—melanoma	0.00116	0.0022	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—AKT1—melanoma	0.00116	0.00219	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP1B1—melanoma	0.00115	0.00217	CbGpPWpGaD
Carbimazole—Rash—Docetaxel—melanoma	0.00107	0.00227	CcSEcCtD
Carbimazole—Dermatitis—Docetaxel—melanoma	0.00107	0.00227	CcSEcCtD
Carbimazole—Headache—Docetaxel—melanoma	0.00106	0.00226	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.00105	0.00199	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PLA2G6—melanoma	0.00102	0.00193	CbGpPWpGaD
Carbimazole—Nausea—Docetaxel—melanoma	0.00101	0.00214	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—E2F1—melanoma	0.000997	0.00188	CbGpPWpGaD
Carbimazole—TPO—Metabolism—VCAN—melanoma	0.000918	0.00173	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—RAC1—melanoma	0.000906	0.00171	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000879	0.00166	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MMP1—melanoma	0.000876	0.00166	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CDK2—melanoma	0.00086	0.00163	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000822	0.00155	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—ATM—melanoma	0.000816	0.00154	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CDK4—melanoma	0.000813	0.00154	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ACER3—melanoma	0.000774	0.00146	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP17A1—melanoma	0.000774	0.00146	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GNA11—melanoma	0.000731	0.00138	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BRAF—melanoma	0.000719	0.00136	CbGpPWpGaD
Carbimazole—TPO—Metabolism—FASN—melanoma	0.000716	0.00135	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CASP8—melanoma	0.000713	0.00135	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—UGT2B10—melanoma	0.000708	0.00134	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—RB1—melanoma	0.000707	0.00134	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CDH1—melanoma	0.000704	0.00133	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SLC5A5—melanoma	0.000704	0.00133	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000699	0.00132	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GNAQ—melanoma	0.00068	0.00128	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CD44—melanoma	0.00068	0.00128	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HS3ST5—melanoma	0.000658	0.00124	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP1B1—melanoma	0.000652	0.00123	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BCL2—melanoma	0.000612	0.00116	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MDM2—melanoma	0.000603	0.00114	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CASP3—melanoma	0.000539	0.00102	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ABCB1—melanoma	0.000537	0.00101	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.00053	0.001	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CCND1—melanoma	0.000525	0.000992	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—melanoma	0.00052	0.000983	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—PTEN—melanoma	0.000507	0.000958	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—melanoma	0.000504	0.000953	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PLCB4—melanoma	0.000499	0.000943	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PRKCA—melanoma	0.000494	0.000934	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ERCC2—melanoma	0.00049	0.000926	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—FASN—melanoma	0.00049	0.000926	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC6A11—melanoma	0.000469	0.000887	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIP4K2A—melanoma	0.000469	0.000887	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—melanoma	0.000458	0.000865	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—MTAP—melanoma	0.000456	0.000863	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000446	0.000843	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MYC—melanoma	0.000421	0.000796	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—melanoma	0.000412	0.000779	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—EGFR—melanoma	0.000412	0.000778	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PHGDH—melanoma	0.000407	0.000769	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—LUM—melanoma	0.000407	0.000769	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HPSE—melanoma	0.000399	0.000754	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CUBN—melanoma	0.000391	0.00074	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—KRAS—melanoma	0.000389	0.000735	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CG—melanoma	0.000387	0.000731	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SDHD—melanoma	0.000378	0.000715	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CSPG4—melanoma	0.000378	0.000715	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—BSG—melanoma	0.000378	0.000715	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PPARG—melanoma	0.000373	0.000706	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GPAM—melanoma	0.000366	0.000692	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—melanoma	0.000346	0.000654	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CD—melanoma	0.00034	0.000643	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ALB—melanoma	0.000336	0.000635	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PLA2G6—melanoma	0.000311	0.000589	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CB—melanoma	0.000296	0.00056	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTGS2—melanoma	0.000294	0.000555	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—melanoma	0.000292	0.000552	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—VCAN—melanoma	0.00028	0.000529	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.000265	0.0005	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTEN—melanoma	0.000256	0.000484	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.000256	0.000483	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP17A1—melanoma	0.000236	0.000446	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.000233	0.00044	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—melanoma	0.00023	0.000434	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GNA11—melanoma	0.000223	0.000421	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—FASN—melanoma	0.000218	0.000412	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC5A5—melanoma	0.000215	0.000405	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GNAQ—melanoma	0.000207	0.000392	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CD44—melanoma	0.000207	0.000392	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	0.000203	0.000383	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	0.000201	0.00038	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP1B1—melanoma	0.000199	0.000375	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CA—melanoma	0.000181	0.000342	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.000175	0.000331	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ABCB1—melanoma	0.000164	0.000309	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PRKCA—melanoma	0.000151	0.000285	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ERCC2—melanoma	0.000149	0.000282	CbGpPWpGaD
Carbimazole—TPO—Metabolism—AKT1—melanoma	0.000148	0.000279	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	0.000124	0.000234	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CG—melanoma	0.000118	0.000223	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PPARG—melanoma	0.000114	0.000215	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CD—melanoma	0.000104	0.000196	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ALB—melanoma	0.000102	0.000193	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CB—melanoma	9.03e-05	0.000171	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTGS2—melanoma	8.95e-05	0.000169	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTEN—melanoma	7.81e-05	0.000148	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CA—melanoma	5.51e-05	0.000104	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AKT1—melanoma	4.5e-05	8.5e-05	CbGpPWpGaD
